Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Abbott Laboratories (NYSE:ABT) has greatly exceeded the broader S&P 500 index this year, with its stock price increasing by 18% compared to the S&P 500’s 6% rise. This strong performance is due to the ...

Members of Congress have traded $ABT stock 13 times in the past 6 months. Of those trades, 6 have been purchases and 7 have been sales. Here’s a breakdown of recent ...

With a market cap of $218.8 billion, Abbott Laboratories (ABT) is a global healthcare leader with a diversified portfolio spanning medical devices, diagnostics, nutrition, and branded generic ...

Abbott Laboratories (NYSE:ABT) is scheduled to announce its second-quarter earnings on Thursday, July 17, 2025. For traders who focus on events, examining the historical reactions of the stock to ...

Recent discussions on X about Abbott Laboratories (ABT) have centered on the company’s latest quarterly earnings and guidance updates. Posts on the platform highlight a mixed reaction to the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to ...